Jump to main content

The weight loss drug Wegovy lowered heart attack risk in a large trial

November 15, 2023
Among 17,000 adults, those on semaglutide were less likely to experience nonfatal heart attacks and strokes or death due to cardiovascular disease. Read more
Reading level: Grade 11
Free science fair projects.